Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Humana Inc (HUM) vs iShares iBoxx $ High Yield Corporate Bond ETF (HYG) Price & Performance

Humana IncTrade
iShares iBoxx $ High Yield Corporate Bond ETFTrade

Price performance (Past 24H)

Key statistics

Humana Inc vs iShares iBoxx $ High Yield Corporate Bond ETF — how do they compare? Humana Inc trades at $450.7 (market cap $46.49B), while iShares iBoxx $ High Yield Corporate Bond ETF trades at $77.16 (market cap $17.89B). The key difference: Humana Inc is far larger — about 2.6× iShares iBoxx $ High Yield Corporate Bond ETF's market cap, and Humana Inc pays a 0.91% dividend while iShares iBoxx $ High Yield Corporate Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and iShares iBoxx $ High Yield Corporate Bond ETF for 59 Days on average.

HUMHYG
Market Cap
$46.49B$17.89B
Volume
2,567,70444,866,592
Sector
HealthFixed Income
52-Week High
$409.85$81.28
52-Week Low
$163.67$76.90
Typical Hold Time
53 Days59 Days
Enterprise Value
$53.84B—
Dividend Yield
0.91%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Humana Inc

Humana (HUM) trades at $396.51, down 1.92% on the day, with strong technical momentum showing bullish moving averages and key support at $391. The company demonstrates consistent revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent quarterly earnings have exceeded expectations, with Q2 2026 EPS of $7.61 beating estimates of $7.27. Analyst sentiment remains positive with a $432.63 consensus price target representing 9% upside potential from current levels.

The investment case centers on Humana's dominant Medicare Advantage position and consistent revenue growth, though margin pressure and regulatory scrutiny present headwinds. With 43% of analysts maintaining buy ratings and institutional accumulation continuing, the stock offers exposure to healthcare demographics but requires monitoring of enrollment trends and cost management execution.

iShares iBoxx $ High Yield Corporate Bond ETF

HYG trades at $77.18, down 0.12% with a bearish technical signal from moving averages. The ETF shows neutral oscillator readings but faces pressure from rising Treasury yields impacting high-yield bond valuations. Recent dividend payments of $0.34-$0.44 provide income support amid market volatility.

The outlook remains challenged by persistent bond market selloffs and higher interest rates, though the current yield environment may attract income-seeking investors. Key risks include further Fed tightening and economic slowdown impacting corporate credit quality.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HUM

No sentiment data available yet.

HYG
57% Buy43% Sell
Avg holding period · 59 Days

Top news

Latest headlines on both assets

About Humana Inc

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Read more on HUM →

About iShares iBoxx $ High Yield Corporate Bond ETF

HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.

Read more on HYG →